Concepedia

Richard E. Cutler

RE

32

Publications

2.3K

Citations

23

H-Index

1990

Active since

Affiliations

Puma Biotechnology (United States)(Current)

Memorial Sloan Kettering Cancer Center

Virginia Commonwealth University

Northwestern University

The University of Texas MD Anderson Cancer Center

Richard E. Cutler is an author at Puma Biotechnology (United States) specializing in medicine, cell biology, and cell signaling.

Top concepts

MedicineCell BiologyCell SignalingTumor BiologyOncologyCancer Cell BiologySignal TransductionOvarian CancerCancer ResearchCancer Biology

Publications per year

1990–2020

32

Publications

32

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

Autoregulation of the Raf-1 serine/threonine kinase

Richard E. Cutler, Robert M. Stephens, Misty Saracino et al. · Proceedings of the National Academy of Sciences · 1998 · 198 citations · Full text

Signal Transduction, Developmental Biology, Signaling Pathway +10

EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation

Torsten Trowe, Sotiria Boukouvala, Keith Calkins et al. · Clinical Cancer Research · 2008 · 132 citations

Heat-shock protein-25/27 phosphorylation by the δ isoform of protein kinase C

Evelyn T. Maizels, Carl A. Peters, Michael Kline et al. · Biochemical Journal · 1998 · 116 citations · Full text

Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer

Sarah Croessmann, Luigi Formisano, Lisa N. Kinch et al. · Clinical Cancer Research · 2018 · 109 citations · Full text

Rows per page

1–5 of 32